NM_020987.5:c.115-45940A>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_020987.5(ANK3):​c.115-45940A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.709 in 151,992 control chromosomes in the GnomAD database, including 38,780 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.71 ( 38780 hom., cov: 31)

Consequence

ANK3
NM_020987.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.00500

Publications

37 publications found
Variant links:
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
  • intellectual disability-hypotonia-spasticity-sleep disorder syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • intellectual disability
    Inheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.882 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANK3NM_020987.5 linkc.115-45940A>G intron_variant Intron 1 of 43 ENST00000280772.7 NP_066267.2 Q12955-3
ANK3NM_001204404.2 linkc.64-45940A>G intron_variant Intron 1 of 43 NP_001191333.1 Q12955-4
ANK3NM_001320874.2 linkc.115-45940A>G intron_variant Intron 1 of 42 NP_001307803.1
ANK3NM_001204403.2 linkc.97-45940A>G intron_variant Intron 2 of 43 NP_001191332.1 Q12955-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANK3ENST00000280772.7 linkc.115-45940A>G intron_variant Intron 1 of 43 1 NM_020987.5 ENSP00000280772.1 Q12955-3

Frequencies

GnomAD3 genomes
AF:
0.709
AC:
107675
AN:
151874
Hom.:
38765
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.574
Gnomad AMI
AF:
0.685
Gnomad AMR
AF:
0.740
Gnomad ASJ
AF:
0.786
Gnomad EAS
AF:
0.721
Gnomad SAS
AF:
0.905
Gnomad FIN
AF:
0.704
Gnomad MID
AF:
0.788
Gnomad NFE
AF:
0.765
Gnomad OTH
AF:
0.738
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.709
AC:
107730
AN:
151992
Hom.:
38780
Cov.:
31
AF XY:
0.712
AC XY:
52865
AN XY:
74290
show subpopulations
African (AFR)
AF:
0.574
AC:
23789
AN:
41428
American (AMR)
AF:
0.741
AC:
11322
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.786
AC:
2726
AN:
3468
East Asian (EAS)
AF:
0.720
AC:
3705
AN:
5146
South Asian (SAS)
AF:
0.904
AC:
4343
AN:
4804
European-Finnish (FIN)
AF:
0.704
AC:
7443
AN:
10572
Middle Eastern (MID)
AF:
0.779
AC:
229
AN:
294
European-Non Finnish (NFE)
AF:
0.765
AC:
51990
AN:
67976
Other (OTH)
AF:
0.739
AC:
1558
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1568
3136
4705
6273
7841
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
832
1664
2496
3328
4160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.748
Hom.:
145001
Bravo
AF:
0.699
Asia WGS
AF:
0.777
AC:
2699
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
2.3
DANN
Benign
0.51
PhyloP100
-0.0050
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10761482; hg19: chr10-62085337; API